HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mutation of galactose-1-phosphate uridyl transferase and its association with ovarian cancer and endometriosis.

Abstract
Impaired galactose metabolism has been proposed as a risk factor for ovarian cancer and endometriosis, which is a putative precursor of endometrioid and clear cell histological sub-types of ovarian cancer. The prevalence of the most common galactose-I-phosphate uridyl transferase gene mutations, Q188R and N314D, was assessed in 206 women with ovarian cancer, 78 women with endometriosis and 248 controls. No Q188R mutations were found in any of the groups. A statistically significant increase in the frequency of N314D mutations was observed in women with serous and undifferentiated histological sub-types of ovarian cancer, but not mucinous, endometrioid or clear cell sub-types. There were no significant differences observed in the N314D mutation frequency between women with endometriosis (18%) and controls (17%). Our results support previous reports of an association of impaired galactose metabolism with serous and undifferentiated ovarian cancers but contradict previous findings of increased N314D mutation frequencies among women with endometriosis and endometrioid and clear cell sub-types ovarian cancer.
AuthorsS J Morland, X Jiang, A Hitchcock, E J Thomas, I G Campbell
JournalInternational journal of cancer (Int J Cancer) Vol. 77 Issue 6 Pg. 825-7 (Sep 11 1998) ISSN: 0020-7136 [Print] United States
PMID9714048 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • UTP-Hexose-1-Phosphate Uridylyltransferase
Topics
  • Adult
  • DNA Primers
  • Endometriosis (enzymology, genetics)
  • Female
  • Humans
  • Mutation
  • Ovarian Diseases (enzymology, genetics)
  • Ovarian Neoplasms (enzymology, genetics)
  • Polymerase Chain Reaction
  • UTP-Hexose-1-Phosphate Uridylyltransferase (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: